Reference laboratory dedicated to the development and commercialization of diagnostic testing for neurological disorders. Provides neurologists and other physicians with diagnostic answers that can improve the quality of health care for patients in a cost effective manner. Athena is a leading provider of advanced neurological diagnostic assays
American Academy of Neurology (AAN)- Special Article- Practive Parameter: Evaluation of the child with microcephaly (an evidence-based review). Objective: To make evidence-based recommendations concerning the evaluation of the child with microcephaly
PubMed Study Abstract: Ten indicators available during the first two hours of life, such as clinical criteria of neonatal distress and postnatal arterial blood gases, were compared
with the neonatal neurological course in sixty full term newborns with significant birth asphyxia in order to test their value for the diagnosis and the short-term prognosis of severe birth asphyxia. Birth asphyxia was defined as severe when it was followed by symptoms of moderate or severe post-asphyxial encephalopathy.
Duke University and Multicenter, Open-label Study to Investigate the Safety,
Tolerability and Pharmacokinetics of Lacosamine (LCM) Oral Solution (syrup) as Adjunctive Therapy in Children with Partial Onset Seizures. This study is being done to test the safety of the study drug Lacosamide (LCM) syrup and how the body processes it.
Effect of treatment on the movement disorder will be measured by a myoclonus scale and a dystonia scale as well as by assessment of overall functional status. Response at various dosages will be compared to baseline for all patients.Safety parameters including neurological examination, blood tests and EKG will be monitored throughout the treatment period and during withdrawal of the medication.
The Global Library of Women's Medicine - Expert clinical resources for women's healthcare . Women's Medicine, 442 peer and expert reviewed chapters - Safer Motherhood, Extensive clinical guidance - Visual Medicine - Lab Tests and more
Mayo research study to determine if there are enough patients with hard to treat epilepsy that might qualify for a future study of a medical device that is being developed to treat epilepsy. Participants will not be testing the device during this study. The study doctor will be assessing seizure type(s) and determine how frequently they occur, and to verify if antiseizure medications can be held constant for a period of 12 weeks.